Enterococcus faecalis inhibits hyphal morphogenesis and virulence of Candida albicans

Infection and Immunity

Volumn 81, Issue 1, 2013, Pages 189-200

  Cruz, Melissa R ^a   Graham, Carrie E ^a   Gagliano, Bryce C ^a   Lorenz, Michael C ^a   Garsin, Danielle A ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; FSR PROTEIN; GELE PROTEIN; PROTEINASE; SERE PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BIOFILM; CANDIDA ALBICANS; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; ENZYME REGULATION; FLUORESCENCE MICROSCOPY; FUNGAL VIRULENCE; FUNGUS HYPHAE; GENE REPRESSION; GENETIC IDENTIFICATION; HEAT TOLERANCE; MICROBIOME; MIXED INFECTION; MORPHOGENESIS; MUTANT; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUORUM SENSING; SIGNAL TRANSDUCTION; SUPERNATANT; TRANSPOSON;

ANIMALS; BACTERIAL PROTEINS; BIOFILMS; CAENORHABDITIS ELEGANS; CANDIDA ALBICANS; CANDIDIASIS; COINFECTION; ENTEROCOCCUS FAECALIS; GRAM-POSITIVE BACTERIAL INFECTIONS; HYPHAE; MORPHOGENESIS; QUORUM SENSING; VIRULENCE;

EID: 84871897954     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00914-12     Document Type: Article

References (63)

1. Morales DK, Hogan DA. 2010. Candida albicans interactions with bacteria in the context of human health and disease. PLoS Pathog. 6:e1000886. doi:10.1371/journal.ppat.1000886.
2. Peleg AY, Hogan DA, Mylonakis E. 2010. Medically important bacterial-fungal interactions. Nat. Rev. Microbiol. 8:340-349.
3. Shirtliff ME, Peters BM, Jabra-Rizk MA. 2009. Cross-kingdom interactions: Candida albicans and bacteria. FEMS Microbiol. Lett. 299:1-8.
4. Noverr MC, Falkowski NR, McDonald RA, McKenzie AN, Huffnagle GB. 2005. Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13. Infect. Immun. 73:30-38.
5. Noverr MC, Noggle RM, Toews GB, Huffnagle GB. 2004. Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect. Immun. 72:4996-5003.
6. Hogan DA, Kolter R. 2002. Pseudomonas-Candida interactions: an ecological role for virulence factors. Science 296:2229-2232.
7. Hogan DA, Vik A, Kolter R. 2004. A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology. Mol. Microbiol. 54:1212-1223.
8. Azoulay E, Timsit JF, Tafflet M, de Lassence A, Darmon M, Zahar JR, Adrie C, Garrouste-Orgeas M, Cohen Y, Mourvillier B, Schlemmer B. 2006. Candida colonization of the respiratory tract and subsequent Pseudomonas ventilator-associated pneumonia. Chest 129:110-117.
9. Neely AN, Law EJ, Holder IA. 1986. Increased susceptibility to lethal Candida infections in burned mice preinfected with Pseudomonas aeruginosa or pretreated with proteolytic enzymes. Infect. Immun. 52:200-204.
10. Bamford CV, d'Mello A, Nobbs AH, Dutton LC, Vickerman MM, Jenkinson HF. 2009. Streptococcus gordonii modulates Candida albicans biofilm formation through intergeneric communication. Infect. Immun. 77:3696-3704.
11. Harriott MM, Noverr MC. 2009. Candida albicans and Staphylococcus aureus form polymicrobial biofilms: effects on antimicrobial resistance. Antimicrob. Agents Chemother. 53:3914-3922.
12. O'Sullivan JM, Jenkinson HF, Cannon RD. 2000. Adhesion of Candida albicans to oral streptococci is promoted by selective adsorption of salivary proteins to the streptococcal cell surface. Microbiology 146(Pt 1):41-48.
13. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK. 2008. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect. Control Hosp. Epidemiol. 29:996-1011.
14. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309-317.
15. Peciuliene V, Reynaud AH, Balciuniene I, Haapasalo M. 2001. Isolation of yeasts and enteric bacteria in root-filled teeth with chronic apical periodontitis. Int. Endod. J. 34:429-434.
16. Wade JJ, Rolando N, Hayllar K, Philpott-Howard J, Casewell MW, Williams R. 1995. Bacterial and fungal infections after liver transplantation: an analysis of 284 patients. Hepatology 21:1328-1336.
17. Mason KL, Erb Downward JR, Falkowski NR, Young VB, Kao JY, Huffnagle GB. 2012. Interplay between the gastric bacterial microbiota and Candida albicans during postantibiotic recolonization and gastritis. Infect. Immun. 80:150-158.
18. Breger J, Fuchs BB, Aperis G, Moy TI, Ausubel FM, Mylonakis E. 2007. Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathog. 3:e18. doi:10.1371/journal.ppat.0030018.
19. Garsin DA, Sifri CD, Mylonakis E, Qin X, Singh KV, Murray BE, Calderwood SB, Ausubel FM. 2001. A simple model host for identifying Gram-positive virulence factors. Proc. Natl. Acad. Sci. U. S. A. 98:10892-10897.
20. Mylonakis E, Casadevall A, Ausubel FM. 2007. Exploiting amoeboid and non-vertebrate animal model systems to study the virulence of human pathogenic fungi. PLoS Pathog. 3:e101. doi:10.1371/journal.ppat.0030101.
21. Peleg AY, Tampakakis E, Fuchs BB, Eliopoulos GM, Moellering RC, Jr, Mylonakis E. 2008. Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans. Proc. Natl. Acad. Sci. U. S. A. 105:14585-14590.
22. Tampakakis E, Peleg AY, Mylonakis E. 2009. Interaction of Candida albicans with an intestinal pathogen, Salmonella enterica serovar Typhimurium. Eukaryot. Cell 8:732-737.
23. Gilmore MS, Coburn PS, Nallapareddy SR, Murray BE. 2002. Enterococcal virulence, p 301-354. In Gilmore MS (ed), The enterococci: pathogenesis, molecular biology and antibiotic resistance. ASM Press, Washington, DC.
24. Moy TI, Ball AR, Anklesaria Z, Casadei G, Lewis K, Ausubel FM. 2006. Identification of novel antimicrobials using a live-animal infection model. Proc. Natl. Acad. Sci. U. S. A. 103:10414-10419.
25. Hope IA. 1999. C. elegans: a practical approach. Oxford University Press, Oxford, United Kingdom.
26. Murray BE, Singh KV, Ross RP, Heath JD, Dunny GM, Weinstock GM. 1993. Generation of restriction map of Enterococcus faecalis OG1 and investigation of growth requirements and regions encoding biosynthetic function. J. Bacteriol. 175:5216-5223.
27. Sahm DF, Kissinger J, Gilmore MS, Murray PR, Mulder R, Solliday J, Clarke B. 1989. In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis. Antimicrob. Agents Chemother. 33:1588-1591.
28. Debroy S, van der Hoeven R, Singh KV, Gao P, Harvey BR, Murray BE, Garsin DA. 2012. Development of a genomic site for gene integration and expression in Enterococcus faecalis. J. Microbiol. Methods 90:1-8.
29. Qin X, Singh KV, Weinstock GM, Murray BE. 2001. Characterization of fsr, a regulator controlling expression of gelatinase and serine protease in Enterococcus faecalis OG1RF. J. Bacteriol. 183:3372-3382.
30. Singh KV, Qin X, Weinstock GM, Murray BE. 1998. Generation and testing of mutants of Enterococcus faecalis in a mouse peritonitis model. J. Infect. Dis. 178:1416-1420.
31. Sifri CD, Mylonakis E, Singh KV, Qin X, Garsin DA, Murray BE, Ausubel FM, Calderwood SB. 2002. Virulence effect of Enterococcus faecalis protease genes and the quorum-sensing locus fsr in Caenorhabditis elegans and mice. Infect. Immun. 70:5647-5650.
32. Qin X, Singh KV, Weinstock GM, Murray BE. 2000. Effects of Enterococcus faecalis fsr genes on production of gelatinase and a serine protease and virulence. Infect. Immun. 68:2579-2586.
33. Bourgogne A, Garsin DA, Qin X, Singh KV, Sillanpaa J, Yerrapragada S, Ding Y, Dugan-Rocha S, Buhay C, Shen H, Chen G, Williams G, Muzny D, Maadani A, Fox KA, Gioia J, Chen L, Shang Y, Arias CA, Nallapareddy SR, Zhao M, Prakash VP, Chowdhury S, Jiang H, Gibbs RA, Murray BE, Highlander SK, Weinstock GM. 2008. Large scale variation in Enterococcus faecalis illustrated by the genome analysis of strain OG1RF. Genome Biol. 9:R110. doi:10.1186/gb-2008-9-7-r110.
34. Garsin DA, Urbach J, Huguet-Tapia JC, Peters JE, Ausubel FM. 2004. Construction of an Enterococcus faecalis Tn917-mediated-gene-disruption library offers insight into Tn917 insertion patterns. J. Bacteriol. 186:7280-7289.
35. Del Papa MF, Perego M. 2008. Ethanolamine activates a sensor histidine kinase regulating its utilization in Enterococcus faecalis. J. Bacteriol. 190: 7147-7156.
36. Sherman F. 1991. Getting started with yeast. Methods Enzymol. 194:3-21.
37. Fonzi WA, Irwin MY. 1993. Isogenic strain construction and gene mapping in Candida albicans. Genetics 134:717-728.
38. Gillum AM, Tsay EY, Kirsch DR. 1984. Isolation of the Candida albicans gene for orotidine-5=-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol. Gen. Genet. 198:179-182.
39. Barelle CJ, Manson CL, MacCallum DM, Odds FC, Gow NA, Brown AJ. 2004. GFP as a quantitative reporter of gene regulation in Candida albicans. Yeast 21:333-340.
40. Keppler-Ross S, Noffz C, Dean N. 2008. A new purple fluorescent color marker for genetic studies in Saccharomyces cerevisiae and Candida albi-cans. Genetics 179:705-710.
41. van der Hoeven R, McCallum KC, Cruz MR, Garsin DA. 2011. Ce-Duox1/BLI-3 generated reactive oxygen species trigger protective SKN-1 activity via p38 MAPK signaling during infection in C. elegans. PLoS Pathog. 7:e1002453. doi:10.1371/journal.ppat.1002453.
42. Nobile CJ, Fox EP, Nett JE, Sorrells TR, Mitrovich QM, Hernday AD, Tuch BB, Andes DR, Johnson AD. 2012. A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell 148:126-138.
43. Nobile CJ, Mitchell AP. 2005. Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p. Curr. Biol. 15:1150-1155.
44. Peters BM, Jabra-Rizk MA, Scheper MA, Leid JG, Costerton JW, Shirtliff ME. 2010. Microbial interactions and differential protein expression in Staphylococcus aureus-Candida albicans dual-species biofilms. FEMS Immunol. Med. Microbiol. 59:493-503.
45. Garsin DA. 2004. Microbiology. Peptide signals sense and destroy target cells. Science 306:2202-2203.
46. Pukkila-Worley R, Peleg AY, Tampakakis E, Mylonakis E. 2009. Candida albicans hyphal formation and virulence assessed using a Caenorhabditis elegans infection model. Eukaryot. Cell 8:1750-1758.
47. Davis-Hanna A, Piispanen AE, Stateva LI, Hogan DA. 2008. Farnesol and dodecanol effects on the Candida albicans Ras1-cAMP signalling pathway and the regulation of morphogenesis. Mol. Microbiol. 67:47-62.
48. Nakayama J, Cao Y, Horii T, Sakuda S, Akkermans AD, de Vos WM, Nagasawa H. 2001. Gelatinase biosynthesis-activating pheromone: a peptide lactone that mediates a quorum sensing in Enterococcus faecalis. Mol. Microbiol. 41:145-154.
49. Bourgogne A, Hilsenbeck SG, Dunny GM, Murray BE. 2006. Comparison of OG1RF and an isogenic fsrB deletion mutant by transcriptional analysis: the Fsr system of Enterococcus faecalis is more than the activator of gelatinase and serine protease. J. Bacteriol. 188:2875-2884.
50. Singh KV, Coque TM, Weinstock GM, Murray BE. 1998. In vivo testing of an Enterococcus faecalis efaA mutant and use of efaA homologs for species identification. FEMS Immunol. Med. Microbiol. 21:323-331.
51. Brown AJ. 2002. Morphogenetic signaling pathways in Candida albicans, p 95-106. In Calderone RA (ed), Candida and candidiasis. ASM Press, Washington, DC.
52. Ramage G, Mowat E, Jones B, Williams C, Lopez-Ribot J. 2009. Our current understanding of fungal biofilms. Crit. Rev. Microbiol. 35:340-355.
53. Harriott MM, Noverr MC. 2011. Importance of Candida-bacterial poly-microbial biofilms in disease. Trends Microbiol. 19:557-563.
54. Shekh RM, Roy U. 2012. Biochemical characterization of an anti-Candida factor produced by Enterococcus faecalis. BMC Microbiol. 12: 132. doi:10.1186/1471-2180-12-132.
55. Shelburne SA, III, Keith D, Horstmann N, Sumby P, Davenport MT, Graviss EA, Brennan RG, Musser JM. 2008. A direct link between carbohydrate utilization and virulence in the major human pathogen group A Streptococcus. Proc. Natl. Acad. Sci. U. S. A. 105:1698-1703.
56. Jarosz LM, Deng DM, van der Mei HC, Crielaard W, Krom BP. 2009. Streptococcus mutans competence-stimulating peptide inhibits Candida albicans hypha formation. Eukaryot. Cell 8:1658-1664.
57. Paulsen IT, Banerjei L, Myers GS, Nelson KE, Seshadri R, Read TD, Fouts DE, Eisen JA, Gill SR, Heidelberg JF, Tettelin H, Dodson RJ, Umayam L, Brinkac L, Beanan M, Daugherty S, DeBoy RT, Durkin S, Kolonay J, Madupu R, Nelson W, Vamathevan J, Tran B, Upton J, Hansen T, Shetty J, Khouri H, Utterback T, Radune D, Ketchum KA, Dougherty BA, Fraser CM. 2003. Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis. Science 299:2071-2074.
58. Biswas S, Van Dijck P, Datta A. 2007. Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. Microbiol. Mol. Biol. Rev. 71:348-376.
59. Thompson DS, Carlisle PL, Kadosh D. 2011. Coevolution of morphology and virulence in Candida species. Eukaryot. Cell 10:1173-1182.
60. Hall RA, De Sordi L, Maccallum DM, Topal H, Eaton R, Bloor JW, Robinson GK, Levin LR, Buck J, Wang Y, Gow NA, Steegborn C, Muhlschlegel FA. 2010. CO(2) acts as a signalling molecule in populations of the fungal pathogen Candida albicans. PLoS Pathog. 6:e1001193. doi:10.1371/journal.ppat.1001193.
61. Klengel T, Liang WJ, Chaloupka J, Ruoff C, Schroppel K, Naglik JR, Eckert SE, Mogensen EG, Haynes K, Tuite MF, Levin LR, Buck J, Muhlschlegel FA. 2005. Fungal adenylyl cyclase integrates CO2 sensing with cAMP signaling and virulence. Curr. Biol. 15:2021-2026.
62. White SJ, Rosenbach A, Lephart P, Nguyen D, Benjamin A, Tzipori S, Whiteway M, Mecsas J, Kumamoto CA. 2007. Self-regulation of Candida albicans population size during GI colonization. PLoS Pathog. 3:e184. doi:10.1371/journal.ppat.0030184.
63. Powell JR, Ausubel FM. 2008. Models of Caenorhabditis elegans infection by bacterial and fungal pathogens. Methods Mol. Biol. 415:403-427.